Brain cancer treatment: Researchers claim that this new drug could help halt the spread of brain cancer
| Updated: Nov 21, 2018, 12:54 IST
Scientists have identified a drug that could potentially help block glioblastoma, the deadliest form of brain cancer. Researchers from Virginia Polytechnic Institute and State University in the US explained that our bodies are largely made of fluids and it helps to move around cells and this is essential to normal body function, however, this fluid sometimes may be doing more harm than good. In glioblastoma, this fluid has a much higher pressure, causing it to move fast and forcing cancer cells to spread.
This study by Virginia Polytechnic Institute and State University may have found a way to stop this. To block the fluid's rapid movement and the spread of cancer cells, they tested a drug called AMD3100. The findings of the study revealed that the drug could help stop the glioblastoma from spreading. "This finding could lead to stopping glioblastoma from spreading," said Cornelison, who was earlier with the University of Virginia, where the majority of the research took place. "I am hopeful that since the drug that we used to block flow stimulation is currently used in patients that maybe clinicians when they do consider using convection-enhanced delivery, will combine that with this drug," he added. "It (glioblastoma) is so deadly, and there hasn't been a shift in treatment response in decades. Something needs to change," said Jennifer Munson, an assistant professor at Virginia Tech.
This study by Virginia Polytechnic Institute and State University may have found a way to stop this. To block the fluid's rapid movement and the spread of cancer cells, they tested a drug called AMD3100. The findings of the study revealed that the drug could help stop the glioblastoma from spreading. "This finding could lead to stopping glioblastoma from spreading," said Cornelison, who was earlier with the University of Virginia, where the majority of the research took place. "I am hopeful that since the drug that we used to block flow stimulation is currently used in patients that maybe clinicians when they do consider using convection-enhanced delivery, will combine that with this drug," he added. "It (glioblastoma) is so deadly, and there hasn't been a shift in treatment response in decades. Something needs to change," said Jennifer Munson, an assistant professor at Virginia Tech.